Sponsor

New York State Psychiatric Institute

Clinical research sponsor

Published trials136
Recruiting shown3
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaNCT07423546 · lead sponsor · 2026-07-01
RECRUITING
Exercise and Olanzapine-samidorphanNCT06740890 · lead sponsor · 2025-06-26
RECRUITING
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialNCT05208190 · lead sponsor · 2022-03-17
RECRUITING
Shared Decision Making for Antipsychotic MedicationsNCT05416658 · lead sponsor · 2027-01-01
NOT_YET_RECRUITING
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNCT07715253 · lead sponsor · 2026-12-01
NOT_YET_RECRUITING
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsNCT07139106 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
DecNef for AVH in SchizophreniaNCT07779226 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Sleep Interventions and Neurocognitive OutcomesNCT05987007 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Using Mobile Technology to Prevent HIV and Related Youth Health ProblemsNCT05130151 · lead sponsor · 2023-08-09
SUSPENDED
D-serine AudRem: R33 PhaseNCT05046353 · lead sponsor · 2022-12-01
SUSPENDED
Anti-suicidal Effects of Buprenorphine In Depressed IndividualsNCT05427981 · lead sponsor · 2022-10-10
WITHDRAWN
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast CancerNCT04973930 · lead sponsor · 2022-03-01
SUSPENDED
A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African WomenNCT04833127 · lead sponsor · 2021-03-17
COMPLETED
Antidepressant Response in Older Adults With Comorbid PTSD and MDDNCT04697693 · lead sponsor · 2021-03-03
TERMINATED
IM Ketamine vs Midazolam for Suicidal ER PatientsNCT04640636 · lead sponsor · 2021-02-09
SUSPENDED
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)NCT04589208 · lead sponsor · 2021-01-01
ACTIVE_NOT_RECRUITING
Mechanisms of Emotion Regulation Underlying Successful CBT in DepressionNCT04328103 · lead sponsor · 2020-11-25
COMPLETED
Using mHealth to Optimize Pharmacotherapy RegimensNCT04248517 · lead sponsor · 2020-10-09
COMPLETED
Ketamine Treatment Effects on Synaptic Plasticity in DepressionNCT04091971 · lead sponsor · 2020-10-09
COMPLETED
OnTrackNY's Learning Healthcare SystemNCT04021719 · lead sponsor · 2019-08-15
SUSPENDED
Cognitive Remediation for Coordinated Specialty CareNCT03930251 · lead sponsor · 2019-06-01
SUSPENDED
Adapting Critical Time Intervention to Support Inpatient Medical Care TransitionNCT03637296 · lead sponsor · 2019-05-01
TERMINATED
D-serine Augmentation of NeuroplasticityNCT03711500 · lead sponsor · 2019-03-13
COMPLETED
ITI-007 (Lumateperone Tosylate) for SchizophreniaNCT03817528 · lead sponsor · 2019-03-01
TERMINATED
Development of Novel Measures for Alzheimer's Disease Prevention TrialsNCT03900273 · lead sponsor · 2019-02-25
SUSPENDED
Contact: Developing New Clinical Management StrategiesNCT03812588 · lead sponsor · 2019-01-30
COMPLETED
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older AdultsNCT03761030 · lead sponsor · 2019-01-09
TERMINATED
Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCVNCT03652675 · lead sponsor · 2018-11-01
COMPLETED
Improving Accessibility and Personalization of CR for SchizophreniaNCT03576976 · lead sponsor · 2018-07-16
COMPLETED
Glutamate Reducing Interventions in SchizophreniaNCT03321617 · lead sponsor · 2018-04-17
COMPLETED
Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)NCT03369249 · lead sponsor · 2017-12-09
COMPLETED
Flavanol Augmentation for Antidepressant Non-Responsive Late Life DepressionNCT02943096 · lead sponsor · 2016-11-01
TERMINATED
Clinical Trial of AVL-3288 in Schizophrenia PatientsNCT02978599 · lead sponsor · 2016-11-01
COMPLETED
A Study of L-DOPA for Depression and Slowing in Older AdultsNCT02744391 · lead sponsor · 2016-08-24
COMPLETED
Remediation of Auditory Recognition in Schizophrenia With tDCSNCT02869334 · lead sponsor · 2016-06-01
COMPLETED
Comparative Effectiveness of Adaptive Treatment Strategies for SchizophreniaNCT02775864 · lead sponsor · 2015-07-01
COMPLETED
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.NCT02255357 · lead sponsor · 2015-03-01
COMPLETED
A Trial of "Opening Doors to Recovery" for Persons With Serious Mental IllnessesNCT04612777 · lead sponsor · 2014-06-15
COMPLETED
Treatment of Psychosis and Agitation in Alzheimer's DiseaseNCT02129348 · lead sponsor · 2014-06-01
COMPLETED
Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDSNCT02140775 · lead sponsor · 2014-04-01
COMPLETED
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for DepressionNCT02750631 · lead sponsor · 2014-04-01
COMPLETED
Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsNCT01973283 · lead sponsor · 2014-02-19
COMPLETED
Mechanisms of Antidepressant Non-Response in Late-Life DepressionNCT01931202 · lead sponsor · 2014-02-19
COMPLETED
Imaging Dopamine Release in DepressionNCT02033369 · lead sponsor · 2014-02-01
COMPLETED
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of SchizophreniaNCT02034474 · lead sponsor · 2014-02-01
COMPLETED
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired ElderlyNCT01951118 · lead sponsor · 2013-10-01
COMPLETED
Ketamine for Suicidality in Bipolar DepressionNCT01944293 · lead sponsor · 2013-09-01
COMPLETED
Personalized and Scalable Cognitive Remediation ApproachesNCT01945333 · lead sponsor · 2013-09-01
COMPLETED
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsNCT01942187 · lead sponsor · 2013-08-01
WITHDRAWN
TDCS for Auditory Hallucinations in SchizophreniaNCT01898299 · lead sponsor · 2013-05-01
COMPLETED
Kuvan in People With Schizophrenia and Schizoaffective DisorderNCT01706965 · lead sponsor · 2012-10-01
COMPLETED
Developing New Clinical Management StrategiesNCT02082392 · lead sponsor · 2012-09-01
COMPLETED
Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health DisorderNCT01854853 · lead sponsor · 2012-08-01
COMPLETED
Olfactory Deficits in MCI as Predictor of Improved Cognition on DonepezilNCT01845636 · lead sponsor · 2012-08-01
COMPLETED
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older AdultsNCT01869374 · lead sponsor · 2012-08-01
COMPLETED
Studying the Effects of Phentermine on Eating BehaviorNCT01886937 · lead sponsor · 2012-07-01
COMPLETED
Ketamine in the Treatment of Suicidal DepressionNCT01700829 · lead sponsor · 2012-06-01
COMPLETED
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic CancerNCT01940237 · lead sponsor · 2012-04-01
TERMINATED
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.NCT01897064 · lead sponsor · 2012-04-01
COMPLETED
Desvenlafaxine vs. Placebo Treatment of Chronic DepressionNCT01537068 · lead sponsor · 2012-02-01
COMPLETED

Sponsor roles

lead sponsor121
collaborator15

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.